AI assistant
Sending…
Anterix Inc. — Director's Dealing 2025
Jan 21, 2025
33018_dirs_2025-01-21_9eb0e0d9-839d-4c35-a50d-e00f84859f11.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2025-01-16
Reporting Person: Guttman-McCabe Christopher (Chief Reg & Comm Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-16 | Stock Option (Right to Buy) | $27.83 | A | 67774 | Acquired | 2035-01-16 | Common Stock (67774) | Direct |
Footnotes
F1: The shares subject to this option shall vest and become exercisable in three equal annual installments with vesting commencing on January 16, 2025, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
More from Anterix Inc.
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Feb 11
Interim / Quarterly Report
2026
Feb 11
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 19